ALZN (STOCKS)
Alzamend Neuro, Inc. Common Stock
$1.230000
+0.020000 (+1.65%)
Prev close: $1.210000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Stephan Jackman
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4.98M
- Employees
- 7
- P/E (TTM)
- -0.28
- P/B (TTM)
- 2.11
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q0)
|
$-0.58 | $-1.96 | +1.3835 | +70.46% |
|
Mar 2026 (Q3)
|
$-0.58 | $-1.96 | +1.3835 | +70.46% |
|
Dec 2025 (Q2)
|
$-0.30 | $-1.99 | +1.6941 | +84.96% |
|
Dec 2025 (Q3)
|
$-0.30 | $-1.99 | +1.6941 | +84.96% |